ASSESSING THE IMPACT OF A MEDICAID PRIOR AUTHORIZATION (PA) POLICY FOR DULOXETINE ON ANTIPSYCHOTIC USE AMONG PATIENTS WITH DEPRESSION

被引：0
|
作者：
Birnbaum, H. G. [1 ]
Ivanova, J. I. [2 ]
Waldman, T. [1 ]
Swallow, E. [1 ]
Cummings, A. K. [1 ]
Clark, T. [3 ]
Peng, X. [3 ]
Swindle, R. [3 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Anal Grp Inc, New York, NY USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1619
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A68 / A69
页数：2
相关论文
共 50 条
  • [31] Impact of Prior Authorization on the Use and Costs of Lipid-Lowering Medications Among Michigan and Indiana Dual Enrollees in Medicaid and Medicare: Results of a Longitudinal, Population-Based Study
    Lu, Christine Y.
    Law, Michael R.
    Soumerai, Stephen B.
    Graves, Amy Johnson
    LeCates, Robert F.
    Zhang, Fang
    Ross-Degnan, Dennis
    Adams, Alyce S.
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 135 - 144
  • [32] Medicare Part D's Impact on Antipsychotic Drug Use and Costs Among Elderly Patients Without Prior Drug Insurance
    Polinski, Jennifer M.
    Brookhart, M. Alan
    Glynn, Robert J.
    Schneeweiss, Sebastian
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 3 - 10
  • [33] Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population
    Ferries, Erin
    Racsa, Patrick
    Bizzell, Brock
    Rhodes, Clay
    Suehs, Brandon
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (05): : 596 - 606
  • [34] DO PRIOR AUTHORIZATION POLICIES DISCOURAGE FIRST-LINE ANTIPSYCHOTIC USE IN PATIENTS NEWLY DISCHARGED FROM A HOSPITALIZATION FOR SCHIZOPHRENIA IN SASKATCHEWAN?
    Blackburn, David F.
    Tran, David
    Crawley, Alex
    Lynds, Sarah
    Champagne, Anne
    Bresee, Lauren
    Remillard, Alfred J.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2014, 21 (01): : E31 - E37
  • [35] Impact of prior and current alcohol use on use of services by patients with depression and chronic medical illnesses
    Jackson, CA
    Manning, WG
    Wells, KB
    HEALTH SERVICES RESEARCH, 1995, 30 (05) : 687 - 705
  • [36] Medicaid enrollment among elderly medicare beneficiaries: Individual determinants, effects of state policy, and impact on service use
    Pezzin, LE
    Kasper, JD
    HEALTH SERVICES RESEARCH, 2002, 37 (04) : 827 - 847
  • [37] Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014
    Fontanella, Cynthia A.
    Hiance-Steelesmith, Danielle L.
    Guirgis, Hossam
    Campo, John V.
    PSYCHIATRIC SERVICES, 2018, 69 (09) : 1015 - 1020
  • [38] EARLY IMPACT OF COVID-19 PANDEMIC ON ANTIPSYCHOTIC MEDICATION USE AMONG PATIENTS WITH SCHIZOPHRENIA
    Pesa, J.
    Liberman, J. N.
    Petrillo, M.
    Ruetsch, C.
    VALUE IN HEALTH, 2021, 24 : S132 - S132
  • [39] Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse
    Zhdanava, Maryia
    Lin, Dee
    Lafeuille, Marie-Helene
    Ghelerter, Isabelle
    Morrison, Laura
    Lefebvre, Patrick
    Joshi, Kruti
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 535 - 548
  • [40] Patterns of marijuana use among psychiatry patients with depression and its impact on recovery
    Bahorik, Amber L.
    Leibowitz, Amy
    Sterling, Stacy A.
    Travis, Adam
    Weisner, Constance
    Satre, Derek D.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 213 : 168 - 171
12345